FIELD: biotechnology.
SUBSTANCE: invention refers to biotechnology, virology, molecular biology and immunology. Described is an agent for specific inhibition of replication of SARS-CoV-2 coronavirus mediated by RNA interference using small interfering RNA (siRNA). Agent for genome SARS-CoV-2 virus replication inhibition, mediated by RNA interference, contains an effective number of molecules of small interfering nucleic acids (siRNA) in the form of complementary duplexes represented with nucleotide sequences selected from a group consisting of SEQ ID NO 4 – SEQ ID NO 33. Recognition of siRNA complexes with virus RNA and its mRNA transcripts results in activation of RNA interference mechanism and attraction of cell enzymes providing degradation of genome RNA of SARS-CoV-2 virus.
EFFECT: invention extends the range of means of inhibiting replication of SARS-CoV-2 coronavirus.
7 cl, 1 tbl, 6 ex, 13 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED DRUG WITH ANTIVIRAL EFFECT AGAINST NEW SARS-COV-2 CORONAVIRUS | 2021 |
|
RU2746362C1 |
| PHARMACEUTICAL COMPOSITIONS, KITS AND METHODS OF TREATING TUMORS | 2019 |
|
RU2810906C2 |
| CRISPR-Cas 12 SYSTEM FOR DETECTING SARS-CoV-2 VIRUS RNA IN ULTRA-LOW CONCENTRATIONS | 2021 |
|
RU2764023C1 |
| METHOD FOR DETECTING SARS-CoV-2 VIRUS RNA IN ULTRA-LOW CONCENTRATIONS AND SPECIFIC OLIGONUCLEOTIDES FOR USE IN THE METHOD | 2021 |
|
RU2764021C1 |
| METHOD FOR OBTAINING A PREPARATION OF THE CRISPR/Cas 12 RIBONUCLEOPROTEIN COMPLEX AND PREPARATION FOR DETECTING SARS-CoV-2 VIRUS RNA IN ULTRA-LOW CONCENTRATIONS | 2021 |
|
RU2764015C1 |
| APPLICATION OF COMPOSITION CONSISTING OF CATIONIC LTP PEPTIDE AND MOLECULES OF RNA AGAINST RESPIRATORY VIRUSES | 2015 |
|
RU2609857C1 |
| CRISPR-CAS14 SYSTEM FOR DETECTING SARS-CoV-2 VIRUS RNA AT ULTRA-LOW CONCENTRATIONS | 2021 |
|
RU2764020C1 |
| SET OF OLIGONUCLEOTIDES AND METHOD OF MULTIPLEX POLYMERASE CHAIN REACTION IN REAL TIME FOR DETECTION OF RNA SARS-COV-2 | 2021 |
|
RU2752902C1 |
| METHOD FOR DETECTING SARS-CoV-2 VIRUS RNA AT ULTRA-LOW CONCENTRATIONS AND SPECIFIC OLIGONUCLEOTIDES FOR USE IN THE METHOD | 2021 |
|
RU2764022C1 |
| METHOD FOR OBTAINING A PREPARATION OF THE RIBONUCLEOPROTEIN COMPLEX CRISPR / Cas14 AND A PREPARATION FOR DETECTING THE RNA OF THE SARS-CoV-2 VIRUS IN ULTRA-LOW CONCENTRATIONS | 2021 |
|
RU2764024C1 |
